Aarti Pharmalabs Ltd.

Further to letter dated May 12, 2023, wherein the company had submitted the Related Party Transactions for the half year ended March 31, 2023 with the Exchanges. The transactions regarding remuneration paid to the Key Managerial Personnel of the Company were inadvertently excluded in its original filing. Accordingly, Aarti Pharmalabs has updated the said transaction details in the enclosed disclosure document.

The above information is a part of company’s filings submitted to BSE.